This data package contains datasets on clinical trials conducted in the United States. Diseases include cervical cancer, diabetes, acute respiratory infection as well as stress. This data package also includes clinical trials registry and results database.

This statistic shows the number of clinical trial participants in the U.S. compared to the rest of the world in 2015-2019, by therapeutic area. In the oncology and hematology area, there were some 9,200 clinical trial participants in the United States whereas there were 25,700 participants in the rest of the world.

The Clinical Trials Registry and Results Database compiles information on publicly and privately supported clinical trial studies on a wide range of diseases and conditions. Its main goal is to provide an easy access to both privately and publicly funded clinical trials information for patients, their family members, healthcare professionals, researchers, and the public.

The pediatric clinical trial market is anticipated to expand at a CAGR of 5.9% during the projected period. The market value is projected to increase from US$ 17,918.1 million in 2024 to US$ 31,661.0 million by 2034. The market was valued at US$ 16,831.0 million in 2023 and grew at a CAGR of 6.5% from 2019 to 2023.

Category-wise Outlook

Country-wise Analysis

The following is an information retrieval test collection that contains:

• 204,855 publicly available clinical trails was crawled from ClinicalTrials.gov.
• 60 topics made up of three types: patient case descriptions, patient case summaries and assessor provided ad-hoc queries, totalling an average of 10.2 queries per topic.
• 4,000 assessor provided relevance assessment for topic, trial pairs.

Further details about the test collection can be found in the following publication:

B. Koopman and G. Zuccon. A test collection for matching patient trials. In Proceedings of the 39th annual international ACM SIGIR conference on research and development in information retrieval, Pisa, July 2016.

The global virtual clinical trials market size is estimated to grow from USD 14.28 billion in 2023 to USD 39 billion by 2035, representing a CAGR of 8.79% during the forecast period 2023-2035.

The Clinical Trials Market Report is Segmented by Phase (Phase I, Phase II, Phase III, and Phase IV), Design (Treatment Studies and Observational Studies), and Geography (North America, Europe, Asia-Pacific, The Middle East and Africa, and South America). The Market Report PDF Offers Values (in USD) for all the Above Segments.

This statistic shows the development of the average length of a clinical trial cycle from 2014 to 2022. The data is based on 12 large-cap and four mid-to-large-cap biopharma companies worldwide and across five major therapy areas: oncology, central nervous system, infectious diseases, metabolic disorders, and cardiovascular. As can be seen, the average length of trials increased with a peak of 7.14 years in 2020.

The Clinical Trial Management Systems Market is Segmented by Delivery Mode (On-Premise and Cloud-Based), Component (Software and Services), End-User (Pharmaceuticals, Clinical Research Organizations, and Other End Users), and Geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America). The Report Offers the Value (in USD) for the Above Segments.

Snapshot img

Clinical Trial Supplies Market Size 2024-2028

The global clinical trial supplies market size is estimated to grow by USD 1.31 billion, at a CAGR of 8.65% between 2023 and 2028.

Biopharma is experiencing significant growth, driven by several key factors. Firstly, there is a rise in the demand for innovative biopharmaceutical products, fueled by advancements in medical research and an increasing focus on personalized medicine. Additionally, government initiatives aimed at promoting clinical research further stimulate industry expansion, providing funding and support for research and development activities and clinical trial support services.
Moreover, the regulation of clinical trials in regional markets ensures compliance with safety and ethical standards, fostering trust and confidence in biopharmaceutical products among healthcare professionals and consumers. These interconnected trends underscore the dynamic landscape of the biopharmaceutical industry, where collaboration between government agencies, research institutions, and industry stakeholders drives innovation and advances healthcare outcomes. As regulatory frameworks evolve and investment in research increases, the market for biopharmaceuticals is poised for continued growth, offering opportunities for improved treatments and medical breakthroughs in various therapeutic areas.

What will be the Size of the Clinical Trial Supplies Market During the Forecast Period?

To learn more about this market report, Download Report Sample

The global clinical trial supply market is experiencing a period of rapid evolution, driven by a combination of factors, including increasing complexity of clinical trials, advancements in technology, and growing demand for clinical research services. Key trends shaping the industry include a shift towards outsourcing of clinical trial supply chain activities, the growing importance of data management and analytics, and a focus on risk mitigation and continuity planning. As clinical trials become more complex and global in scope, there is a rising demand for specialized clinical trial supply services, including sourcing, logistics, and storage of clinical trial materials. Clinical trial supply forecasting has become a crucial aspect of this market, allowing for more accurate predictions in terms of demand, inventory management, and distribution to avoid costly delays and shortages.
Biopharmaceutical companies are increasingly seeking efficient clinical trial supply management strategies to ensure timely delivery of biological drugs to clinical sites worldwide. The clinical trial supplies industry plays a pivotal role in meeting these needs by ensuring that the required materials are available when and where they are needed, with a focus on minimizing waste and optimizing inventory levels. Supply chain management in clinical trials is becoming more sophisticated, driven by the increasing need to manage and coordinate resources across different regions and time zones. Additionally, the growing emphasis on biological drugs in clinical research has led to new challenges in sourcing and transporting temperature-sensitive materials.
The Clinical Trial Supplies Market is evolving with the increasing demand for regulatory-compliant logistics and cold chain distribution to ensure the safe delivery of trial materials. Comparator drug sourcing and direct-to-patient shipments are becoming more common, supported by decentralized trial support systems. Real-time tracking solutions and digital supply management are enhancing transparency and efficiency across the supply chain. GMP-certified packaging and temperature-controlled storage ensure the integrity of biologics trial supplies. Adaptive trial supply strategies, just-in-time inventory, and on-demand labeling solutions are optimizing resource allocation. Blockchain traceability further improves supply chain security, while decentralized models and advanced logistics capabilities continue to shape the future of clinical trials.

How is the Clinical Trial Supplies Market Segmented?

The clinical trial supplies market research report provides comprehensive data (region wise segment analysis), with forecasts and estimates in 'USD billion' for the period 2024-2028, as well as historical data from 2018 - 2022 for the following segments.

End-user

  Pharmaceutical industry
  Biologics industry
  Medical device industry


Type

  Phase III
  Phase II
  Phase IV and BE/BA studies
  Phase I


Service

  Manufacturing
  Packaging and Labeling
  Storage and Distribution
  Comparator Sourcing
  Ancillary Supplies
  Others


Therapeutic Area

  Oncology
  Cardiovascular Diseases
  Neurology
  Infectious Diseases
  Metabolic Disorders
  Others


Distribution Channel

  Direct-to-Site
  Depot-to-Site
  Others


Geography

  North America

    US
    Canada
    Mexico


  Europe

    Germany
    UK
    France

Report Scope:

ravistech/clinical-trial-llm-1k dataset hosted on Hugging Face and contributed by the HF Datasets community

Global Clinical Trial Imaging Market market size valued at $1287.5 Million in 2023, set to reach $2628.37 Million by 2032, a CAGR of 7.4% from 2024 to 2032.

The global clinical trial kits market is anticipated to grow up to USD 2.85 billion by 2030 according to a new study by Polaris Market Research.

The probability that a cancer drug will make it from phase I to final approval stood at some 2.4 percent, according to a study published in March 2020. The data is based on clinical success rate models from 2014, 2016, and 2019. Once a cancer drug made it into phase III, the chances to make it to final approval increased to 35.5 percent.

E-Clinical Solutions Market size was valued at USD 6.5 Billion in 2023 and is projected to reach USD 15.2 Billion by 2031, growing at a CAGR of 11.2% from 2024 to 2031.

Key Market Drivers
• Rising Demand for Clinical Trials Efficiency: With increasing drug discovery and development, the need for faster and more efficient clinical trials is growing fueling demand for e-clinical solutions.
• Advancements in Healthcare IT: The growing integration of healthcare IT solutions is driving the adoption of advanced clinical management tools.
• Regulatory Pressure: Stricter regulatory requirements for clinical trials, particularly regarding data accuracy and patient safety, are pushing for the adoption of e-clinical solutions.
• Increasing Outsourcing to CROs: Contract Research Organizations (CROs) are increasingly using e-clinical tools to manage outsourced clinical trials, further boosting market growth.

The clinical trial software market is expected to grow at CAGR of 14% during the forecast period

The global AI in Clinical Trials market size is estimated to grow from USD 1.82 billion in 2025 to USD 8.5 billion by 2035, representing a CAGR of 16.7% during the forecast period 2025-2035.

Report summarising Wellcome clinical trial compliance monitoring analysis for 2018-2022, alongside the raw data used to compile this report.

The data were analysed and the report written in September 2022.

Explore the Clinical Trial Imaging Market trends! Covers key players, growth rate 9.3% CAGR, market size $2.26 Billion, and forecasts to 2033. Get insights now!